How Bayer Survived the Roundup Crisis

In 2018, Bayer acquired Monsanto for $63 billion, inheriting tens of thousands of lawsuits over the weedkiller Roundup and its alleged link to cancer. By 2020, Bayer's stock had lost nearly half its value and the company faced a potential breakup. But instead of filing for bankruptcy or spinning off its agricultural division, Bayer chose a different path: it restructured its legal strategy, set up a $10 billion settlement fund, and overhauled its corporate governance. This episode of The Pivot Podcast examines how one of the world's oldest pharmaceutical and chemical companies navigated a liability crisis that could have destroyed it. Lucas and Luna break down the specific decisions—from the appointment of a new CEO to the creation of a scientific advisory board—that allowed Bayer to survive without sacrificing its core business. They also explore what other companies facing mass-tort litigation can learn from Bayer's playbook. #Bayer #Monsanto #Roundup #Glyphosate #MassTort #CorporateCrisis #Liability #Litigation #Agribusiness #Pharma #BusinessPivot #Survival #Turnaround #CropScience #LegalStrategy #CEO #Governance #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo